Silvio Ligia | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
Direct oral Anticoagulants (DOACs) in the Onco-Hematologic Patients	MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES	2025
Ropeginterferon alfa-2b treatment in a young patient with multi-refractory polycythemia vera and double JAK2 gene mutation: a case report	FRONTIERS IN ONCOLOGY	2024
Secondary prophylaxis of venous thromboembolism (VTE) with low dose apixaban or rivaroxaban in major-thrombophilia carriers	ANNALS OF HEMATOLOGY	2024
Antithrombotic secondary prophylaxis with low dose of apixaban or rivaroxaban in the onco-hematologic patients: comparison with non-neoplastic patients	ANNALS OF HEMATOLOGY	2023
Early clearance of hairy cell leukaemia in the bone marrow after first‐line treatment with cladribine predicts a favourable outcome	BRITISH JOURNAL OF HAEMATOLOGY	2023
Direct Oral Anticoagulants In Patients With Hematologic Malignancies	HEMATOLOGICAL ONCOLOGY	2020
Prognostic significance of PET/CT in patients with chronic lymphocytic leukemia (CLL) treated with frontline chemoimmunotherapy	CANCERS	2020